Archives

by in
Entry Author Date Location
Biogen Idec Closing San Diego Center, Cadence Wins FDA Approval, Adventrx Files New Drug Application, & More San Diego Life Sciences News 11/04/10 San Diego
Biogen Idec Chief Aims to Make Firm More Like Biotech and Less Like Pharma with Restructuring Plan 11/04/10 Boston
Biogen Idec Axes 650 Jobs, Closes San Diego Site, Bets Future on Neurology 11/03/10 Boston
Exelixis Seeks to Climb From the Penalty Box, Prove its Lead Drug Still Has Legs 10/20/10 San Francisco
5 Biotech Storylines to Watch in Boston 10/13/10 Boston
Exelixis Nabs $60M Upfront, Potentially $505M More, From New Deal With Bristol-Myers 10/11/10 San Francisco
Arena Signs Deal With Eisai for Lorcaserin, Qualcomm CEO Identifies Two Opportunities in Mobile Health, & More San Diego Life Sciences News 07/08/10 San Diego
Exelixis CEO Takes Biogen Gig, What Drives Brook Byers Crazy, The Mission Bay Biotech Cluster, & More Bay Area Life Sciences News 07/02/10 San Francisco
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
New CEO George Scangos Says Biogen Idec’s R&D Has to Improve 07/01/10 Boston
Exelixis Promotes Morrissey to CEO, Replacing Scangos as He Heads to Biogen Idec 06/30/10 San Francisco
Reports: Biogen Picks Exelixis Chief George Scangos as New CEO 06/30/10 Boston
Bristol-Myers Dumps Exelixis Drug 06/21/10 San Francisco
Page 2 of 2 « previous page